SYNCOM FORMULATION (INDIA)
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Syncom Formulation (India) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.61₹ 0.1
As on Nov 3, 2025, 4:01 PM IST
Syncom Formulation (India) Price Performance
Today's LowToday's High
₹16.22₹16.74
₹16.60
52 Weeks' Low52 Weeks' High
₹14.10₹23.95
₹16.60
Open Price
₹16.22
Prev. Close
₹16.50
Volume
1,55,473
Over the last 5 years, the share price of Syncom Formulation (India) has gained 63.75% CAGR. Over the past year, the corresponding return has been -20.31%.
Syncom Formulation (India)’s current P/E of 27.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Syncom Formulation (India) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syncom Formulation (India) | -0.36 | 0.97 | -7.83 | 2.34 | -20.31 | 27.44 | 63.75 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
Over the last one year, Syncom Formulation (India) has declined 20.31% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Syncom Formulation (India) has outperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Syncom Formulation (India) Financials
Syncom Formulation (India) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 16.63 | 16.61 |
| 10 | 16.61 | 16.62 |
| 20 | 16.63 | 16.69 |
| 50 | 17 | 17.06 |
| 100 | 17.96 | 17.51 |
| 200 | 17.81 | 17.74 |
Syncom Formulation (India) Share Holding Pattern
In the latest quarter, Syncom Formulation (India) remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.10%, and public shareholding moved up to 49.33% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Syncom Formulation (India) Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 16, 2025, 11:49 PM IST | Syncom Formul. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 11:39 PM IST | Syncom Formul. - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 01, 2025, 11:36 PM IST | Syncom Formul. - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association |
| Oct 01, 2025, 11:30 PM IST | Syncom Formul. - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 01, 2025, 11:26 PM IST | Syncom Formul. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Syncom Formulation (India)
Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 462.85 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address7, Niraj Industrial Estate, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Kedarmal Shankarlal BankdaExe.Chairman & W T D
- Mr. Vijay Shankarlal BankdaManaging Director
- Mrs. Rinki Ankit BankdaWhole Time Director
- Mrs. Ruchi JindalIndependent Woman Director
- Mr. Ritesh Kumar LunkadIndependent Director
- Mr. Ankit JainIndependent Director
FAQs on Syncom Formulation (India) Share Price
What is the share price of Syncom Formulation (India)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syncom Formulation (India) is ₹16.60 as on Nov 03, 2025.
What kind of stock is Syncom Formulation (India)?
The Syncom Formulation (India) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Syncom Formulation (India)?
The market cap of Syncom Formulation (India) is ₹1,560.40 Cr as on Nov 03, 2025.
What are today's High and Low prices of Syncom Formulation (India)?
Today’s highest and lowest price of Syncom Formulation (India) are ₹16.74 and ₹16.22.
What are the 52 Week High and 52 Week Low of Syncom Formulation (India)?
The 52-week high/low is the highest and lowest price at which Syncom Formulation (India) stock has traded in the past 52-week or nearly a year. The 52-week high of Syncom Formulation (India) is ₹23.95 and 52-week low of Syncom Formulation (India) is ₹14.10 as on Nov 03, 2025.
How has the Syncom Formulation (India) performed historically in terms of returns?
The Syncom Formulation (India) has shown returns of 0.61% over the past day, 0.97% for the past month, -7.83% over 3 months, -20.31% over 1 year, 27.44% across 3 years, and 63.75% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Syncom Formulation (India)?
P/E ratio of and PB ratio of Syncom Formulation (India) are 27.11 and 4.56 on Nov 03, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse